Short-Course Treatment of Community-Acquired Pneumonia

Mandell, Lionel A.; File Jr., Thomas M.
September 2003
Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p761
Academic Journal
Editorial. Comments on the short-course treatment of community-acquired pneumonia (CAP). Acceptance of the time interval of one to two weeks as a rule of thumb for length of treatment of most patients; Attempts to shorten the duration of therapy due to concern regarding antimicrobial resistance; Feasibility of a short-course treatment for CAP.


Related Articles

  • Battling Penicillin-Resistant Pneumonia.  // USA Today Magazine;Feb2001, Vol. 129 Issue 2669, p8 

    Reports that a class of antibiotics known as fluoroquinolones can counter infections, such as pneumonia, caused by penicillin-resistant strains of a common pathogen. Background information on the drug; Contraindications and side effects of the drug.

  • Risk Factors for Acquisition of Levofloxacin-Resistant Streptococcus pneumoniae: A Case-Control Study. Ho, P. L.; Cheng, Vincent C. C.; Chan, Robert M. T.; Tsang, Kenneth W. T.; Kwok, T. K.; Tse, W. S.; Ng, T. K. // Clinical Infectious Diseases;3/1/2001, Vol. 32 Issue 5, p701 

    Presents information on a study which identified the risk factors associated with the acquisition of levofloxacin-resistant Streptococcus pneumoniae infection. Methodology; Results of the study; Discussion.

  • Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults. Martinez, Esteban; Miro, Jose M.; Almirnate, Benito; Aguado, Jose M.; Fernandez-Viladrich, Pedro; Fernandez-Guerrero, Manuel L.; Villanueva, Jose L.; Dronda, Fernando; Moreno-Torrico, Alfonso; Montejo, Miguel; Llinares, Pedro; Gatell, Jose M. // Clinical Infectious Diseases;7/15/2002, Vol. 35 Issue 2, p130 

    Details a study which examined the effect of penicillin resistance of Streptococcus pneumoniae on the treatment of pneumococcal endocarditis (PE) in adults. Incidence of PE; Clinical presentation and complications of PE; Treatment of PE according to the antimicrobial susceptibility of isolates.

  • Antibiotic Use and Resistance in the Pneumococcus.  // Clinical Infectious Diseases;11/15/2006, Vol. 43 Issue 10, pv 

    The article presents information on a topic related to the treatment of streptococcus pneumoniae by scientists M. Prudhomme, L. Attaiech and G. Sanchez published in the 2006 issue of the journal "Science." According to the scientists, transfer of DNA in Streptococcus pneumoniae is completed by...

  • Clinical Pharmacology of the Fluoroquinolones: Studies in Human Dynamic/Kinetic Models. Schentag, Jerome J. // Clinical Infectious Diseases;8/1/2000 Supplement 2, Vol. 31, pS40 

    Explores the clinical pharmacology of the fluoroquinolones by using data from studies of patients with nocosomial gram-negative pneumonia. Bacterial resistance; Bacterial eradication; Pharmacodynamics of newer quinolones; Multi-dose of pharmacokinetics of 4 fluoroquinolones.

  • Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. Francisco Soriano; Fabio Cafini; Lorenzo Aguilar; David Tarragó; Luis Alou; Maria-Jose Giménez; Matilde Gracia; Maria-Carmen Ponte; Denisa Leu; Marina Pana; Iwona Letowska; Asuncion Fenoll // Journal of Antimicrobial Chemotherapy (JAC);Dec2008, Vol. 62 Issue 6, p1234 

    : Objectives To phenotypically and genotypically characterize 11 strains (isolated in four different centres) exhibiting penicillin MIC of 8–32 mg/L among isolates of the SPICE project. Nine isolates were from Romania (9/162; 5.56%) and two from Poland (2/305; 0.66%). : Methods In vitro...

  • Opinion: Generic penicillins: boosted by FDA's back-to-basics for S.pneumoniae.  // PharmaWatch: Monthly Review;Jun2008, Vol. 7 Issue 6, p25 

    The author reflects on the impact of changes made by the U.S. Food and Drug Administration regarding the determination of the susceptibility cut-off for penicillins in the treatment of Streptococcus pneuomoniae pneumonia on antibiotic resistance. The author said that the decision will result...

  • Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Hashemi, Seyyed Hamid; Soozanchi, Golnoosh; Jamal-Omidi, Shirin; Yousefi-Mashouf, Rasoul; Mamani, Mojgan; Seif-Rabiei, Mohammad-Ali // Tropical Doctor;Apr2010, Vol. 40 Issue 2, p89 

    This study was undertaken in order to compare the frequency of bacterial agents of community-acquired pneumonia (CAP) and their antimicrobial resistance in the elderly and younger adults admitted to a teaching hospital in Hamedan, Iran. A total of 150 cases of CAP, including 81 elderly and 69...

  • Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery. Allou, Nicolas; Kermarrec, Nathalie; Muller, Claudette; Thabut, Gabriel; Philip, Ivan; Lucet, Jean-Christophe; Montravers, Philippe // Journal of Antimicrobial Chemotherapy (JAC);Apr2010, Vol. 65 Issue 4, p806 

    The article discusses the results of a study on the risk factors and therapeutic management of post-operative pneumonia (POP) as the main complication among patients undergoing cardiac surgery due to Pseudomonas aeruginosa. According to the authors, the risk of multi-drug resistance pathogens in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics